US labelling rule for injectable drugs aims to reduce risk of death
This article was originally published in Scrip
The US Pharmacopeial Convention has issued new labelling requirements for injectable drugs that will standardise the information permitted on the highly visible area of vials to only cautionary statements intended to prevent imminent life-threatening situations.
You may also be interested in...
While good clinical practice inspectors in the UK and the US collaborate on matters of common interest, they say that mutual recognition is simply not possible.
Whoever takes over as chair of the Medicines and Healthcare products Regulatory Agency will play a key role in its plans to deliver a program of “ambitious business change.”
The International Council for Harmonisation has replaced its 1993 guideline on reproductive toxicity studies with an updated version.